GM1 Gangliosidoses clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Prenatal Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis
Sorry, not yet accepting patients
This is a study for the administration of in utero AAV9 transfer in prenatally diagnosed Type I or Type II GM1.
at UCSF
Last updated: